Wanbury Receives Nine USFDA Letters on Metformin HCl DMFs
Wanbury Ltd says it received nine USFDA letters stating there were no deficiencies in its Metformin HCl drug master files.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Wanbury Ltd says it received nine USFDA letters stating there were no deficiencies in its Metformin HCl drug master files.